Quantitative and in vivo activity of adenoviral-producing cells made by cotransduction of a replication-defective adenovirus and a replication-enabling plasmid

Cancer Gene Therapy

Volumn 3, Issue 4, 1996, Pages 230-237

  Dion, L David ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Adenoviridae; Adenovirus E1 proteins; Genetic vectors; Neoplasms

Indexed keywords

ADENOVIRUS; ANIMAL; ARTICLE; DEFECTIVE VIRUS; GENE EXPRESSION REGULATION; GENETIC RECOMBINATION; GENETIC TRANSDUCTION; GENETICS; HELA CELL; HUMAN; MOUSE; PHYSIOLOGY; PLASMID; TRANSGENE; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; DEFECTIVE VIRUSES; GENE EXPRESSION REGULATION, VIRAL; HELA CELLS; HUMANS; MICE; PLASMIDS; RECOMBINATION, GENETIC; TRANSDUCTION, GENETIC; TRANSGENES; VIRUS REPLICATION;

EID: 0030180017     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Culver KW, Ram Z, Wallbridge S, et al. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 1992;256:1550-1552.
2. Oldfield EH, Ram Z, Culver KW, et al. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Human Gene Ther. 1993;4:39-69.